Naveed Sattar
Title
Cited by
Cited by
Year
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on …
MF Piepoli, AW Hoes, S Agewall, C Albus, C Brotons, AL Catapano, ...
European heart journal 37 (29), 2315-2381, 2016
53172016
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and …
B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ...
European heart journal 39 (33), 3021-3104, 2018
34282018
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
Emerging Risk Factors Collaboration
The Lancet 375 (9733), 2215-2222, 2010
32072010
Genetic studies of body mass index yield new insights for obesity biology
AE Locke, B Kahali, SI Berndt, AE Justice, TH Pers, FR Day, C Powell, ...
Nature 518 (7538), 197-206, 2015
26582015
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
N Sattar, D Preiss, HM Murray, P Welsh, BM Buckley, AJM de Craen, ...
The Lancet 375 (9716), 735-742, 2010
25422010
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Q Yang, TE Graham, N Mody, F Preitner, OD Peroni, JM Zabolotny, ...
Nature 436 (7049), 356-362, 2005
24702005
Major lipids, apolipoproteins, and risk of vascular disease
R Assessment
Jama 302 (18), 1993-2000, 2009
22042009
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular …
Authors/Task Force Members, L Rydén, PJ Grant, SD Anker, C Berne, ...
European heart journal 34 (39), 3035-3087, 2013
2149*2013
Diabetes mellitus, fasting glucose, and risk of cause-specific death
Emerging Risk Factors Collaboration
New England Journal of Medicine 364 (9), 829-841, 2011
19572011
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study
N Sattar, A Gaw, O Scherbakova, I Ford, DSJ O’Reilly, SM Haffner, C Isles, ...
Circulation 108 (4), 414-419, 2003
19312003
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
MJL Peters, DPM Symmons, D McCarey, BAC Dijkmans, P Nicola, ...
Annals of the rheumatic diseases 69 (2), 325-331, 2010
17592010
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
KK Ray, SRK Seshasai, S Wijesuriya, R Sivakumaran, S Nethercott, ...
The Lancet 373 (9677), 1765-1772, 2009
15332009
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ...
Jama 305 (24), 2556-2564, 2011
14952011
Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis
N Sattar, DW McCarey, H Capell, IB McInnes
Circulation 108 (24), 2957-2963, 2003
11952003
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study
DJ Freeman, J Norrie, N Sattar, RDG Neely, SM Cobbe, I Ford, C Isles, ...
Circulation 103 (3), 357-362, 2001
11722001
Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS)
AM Wallace, AD McMahon, CJ Packard, A Kelly, J Shepherd, A Gaw, ...
Circulation 104 (25), 3052-3056, 2001
11092001
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
E Di Angelantonio, SN Bhupathiraju, D Wormser, P Gao, S Kaptoge, ...
The Lancet 388 (10046), 776-786, 2016
10622016
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
DW McCarey, IB McInnes, R Madhok, R Hampson, O Scherbakova, I Ford, ...
The Lancet 363 (9426), 2015-2021, 2004
10192004
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study
DJ Freeman, J Norrie, MJ Caslake, A Gaw, I Ford, GDO Lowe, ...
Diabetes 51 (5), 1596-1600, 2002
10162002
C-reactive protein, fibrinogen, and cardiovascular disease prediction
Emerging Risk Factors Collaboration
New England Journal of Medicine 367 (14), 1310-1320, 2012
9312012
The system can't perform the operation now. Try again later.
Articles 1–20